Viewing Study NCT04641234


Ignite Creation Date: 2025-12-25 @ 2:29 AM
Ignite Modification Date: 2025-12-28 @ 12:15 AM
Study NCT ID: NCT04641234
Status: COMPLETED
Last Update Posted: 2022-06-10
First Post: 2020-11-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study Reviewing Medical Records to Learn More About Treat-and-extend With Eylea in Patients With Neovascular Age-related Macular Degeneration (nAMD).
Sponsor: Bayer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module